These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11282762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation.
    O'Donnell DE, Bain DJ, Webb KA.
    Am J Respir Crit Care Med; 1997 Feb; 155(2):530-5. PubMed ID: 9032190
    [Abstract] [Full Text] [Related]

  • 4. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
    Peters MM, Webb KA, O'Donnell DE.
    Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease.
    Eves ND, Petersen SR, Haykowsky MJ, Wong EY, Jones RL.
    Am J Respir Crit Care Med; 2006 Oct 01; 174(7):763-71. PubMed ID: 16840742
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE.
    Thorax; 2008 Jul 01; 63(7):606-13. PubMed ID: 18250181
    [Abstract] [Full Text] [Related]

  • 14. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life.
    Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U.
    Am J Respir Crit Care Med; 2000 Nov 01; 162(5):1709-14. PubMed ID: 11069801
    [Abstract] [Full Text] [Related]

  • 15. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
    Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE.
    Am J Respir Crit Care Med; 2009 Nov 15; 180(10):964-71. PubMed ID: 19897773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar 15; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.